(-)-epigallocatechin 3-gallate increases expression ISO WNT5A (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of WNT5A mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate multiple interactions ISO WNT5A (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of WNT5A mRNA CTD PMID:22079256 (-)-gambogic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 gambogic acid results in decreased expression of WNT5A mRNA and gambogic acid results in decreased expression of WNT5A protein CTD PMID:33533530 (R)-lipoic acid multiple interactions ISO Wnt5a (Mus musculus) 6480464 Thioctic Acid inhibits the reaction [Sodium Fluoride results in increased expression of WNT5A protein] CTD PMID:37739047 1,1-dichloroethene decreases expression ISO Wnt5a (Mus musculus) 6480464 vinylidene chloride results in decreased expression of WNT5A mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO Wnt5a (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of WNT5A mRNA CTD PMID:22206623 1,4-benzoquinone increases expression ISO WNT5A (Homo sapiens) 6480464 quinone results in increased expression of WNT5A mRNA CTD PMID:22960397 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of WNT5A mRNA CTD PMID:21058326 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of WNT5A mRNA CTD PMID:16551644 17beta-estradiol multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of WNT5A mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol decreases expression ISO WNT5A (Homo sapiens) 6480464 Estradiol results in decreased expression of WNT5A mRNA CTD PMID:31614463 and PMID:31646340 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of WNT5A mRNA CTD PMID:31119341 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of WNT5A mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO Wnt5a (Mus musculus) 6480464 Estradiol results in increased expression of WNT5A mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO WNT5A (Homo sapiens) 6480464 Estradiol results in increased expression of WNT5A mRNA CTD PMID:19619570 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO WNT5A (Homo sapiens) 6480464 2 more ... CTD PMID:22262711 2,3,7,8-tetrachlorodibenzodioxine decreases secretion ISO Wnt5a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased secretion of WNT5A protein CTD PMID:26572662 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT5A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Wnt5a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of WNT5A mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO WNT5A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT5A mRNA and Tetrachlorodibenzodioxin results in increased expression of WNT5A protein CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Wnt5a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of WNT5A mRNA CTD PMID:17586704 and PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO WNT5A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of WNT5A mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of WNT5A mRNA CTD PMID:19619570 2-hydroxypropanoic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 Lactic Acid results in decreased expression of WNT5A mRNA CTD PMID:30851411 2-palmitoylglycerol increases expression ISO WNT5A (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of WNT5A mRNA CTD PMID:37199045 3',5'-cyclic AMP multiple interactions ISO WNT5A (Homo sapiens) 6480464 WNT5A protein affects the reaction [[Medroxyprogesterone Acetate results in increased abundance of Cyclic AMP] which results in increased expression of SOD2 mRNA] and WNT5A protein affects the reaction [Medroxyprogesterone Acetate results in increased abundance of Cyclic AMP] CTD PMID:20685861 3,3',4,4',5-pentachlorobiphenyl increases expression ISO WNT5A (Homo sapiens) 6480464 3 more ... CTD PMID:22262711 and PMID:35618242 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine increases expression ISO Wnt5a (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of WNT5A mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine affects methylation ISO Wnt5a (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine affects the methylation of WNT5A promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression ISO Wnt5a (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of WNT5A mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol decreases expression ISO WNT5A (Homo sapiens) 6480464 bisphenol S results in decreased expression of WNT5A mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol affects methylation ISO Wnt5a (Mus musculus) 6480464 bisphenol S affects the methylation of WNT5A gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO Wnt5a (Mus musculus) 6480464 bisphenol S results in decreased methylation of WNT5A exon CTD PMID:33297965 4-hydroxyphenyl retinamide decreases expression ISO Wnt5a (Mus musculus) 6480464 Fenretinide results in decreased expression of WNT5A mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases expression ISO WNT5A (Homo sapiens) 6480464 Decitabine results in decreased expression of WNT5A mRNA and Decitabine results in decreased expression of WNT5A protein CTD PMID:30125549 5-azacytidine increases expression ISO WNT5A (Homo sapiens) 6480464 Azacitidine results in increased expression of WNT5A mRNA CTD PMID:20823114 5-fluorouracil increases expression ISO WNT5A (Homo sapiens) 6480464 Fluorouracil results in increased expression of WNT5A mRNA CTD PMID:31711903 5-fluorouracil multiple interactions EXP 150530464 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon] RGD 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of WNT5A mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of WNT5A mRNA CTD PMID:30047161 acetaldehyde affects expression ISO Wnt5a (Mus musculus) 6480464 Acetaldehyde affects the expression of WNT5A mRNA CTD PMID:22634333 acrolein multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of WNT5A mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of WNT5A mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO WNT5A (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of WNT5A mRNA CTD PMID:22100608 and PMID:27153756 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of WNT5A mRNA CTD PMID:18004065 aldehydo-D-glucose increases expression ISO WNT5A (Homo sapiens) 6480464 Glucose results in increased expression of WNT5A mRNA CTD PMID:29163160 aldehydo-D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA] CTD PMID:18004065 all-trans-retinoic acid decreases expression ISO Wnt5a (Mus musculus) 6480464 Tretinoin results in decreased expression of WNT5A mRNA CTD PMID:16604517 all-trans-retinoic acid multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] results in increased expression of WNT5A mRNA CTD PMID:31711903 all-trans-retinoic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 Tretinoin results in decreased expression of WNT5A mRNA CTD PMID:31711903 all-trans-retinoic acid increases expression ISO WNT5A (Homo sapiens) 6480464 Tretinoin results in increased expression of WNT5A mRNA CTD PMID:21934132 alpha-pinene multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of WNT5A mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of WNT5A mRNA CTD PMID:32699268 amitrole increases expression EXP 6480464 Amitrole results in increased expression of WNT5A mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of WNT5A mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO WNT5A (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of WNT5A mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO WNT5A (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of WNT5A mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO WNT5A (Homo sapiens) 6480464 arsenite results in increased expression of WNT5A mRNA CTD PMID:19061910 arsenite(3-) multiple interactions ISO WNT5A (Homo sapiens) 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of WNT5A mRNA] CTD PMID:31646340 arsenite(3-) decreases expression ISO WNT5A (Homo sapiens) 6480464 arsenite results in decreased expression of WNT5A mRNA CTD PMID:31646340 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of WNT5A mRNA and Atrazine results in decreased expression of WNT5A protein CTD PMID:31187311 azoxystrobin decreases expression ISO WNT5A (Homo sapiens) 6480464 azoxystrobin results in decreased expression of WNT5A mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO WNT5A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of WNT5A mRNA and Benzo(a)pyrene results in increased expression of WNT5A protein CTD PMID:20064835 and PMID:21802500 benzo[a]pyrene decreases methylation ISO WNT5A (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of WNT5A 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Wnt5a (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of WNT5A mRNA CTD PMID:22228805 beta-naphthoflavone increases expression ISO WNT5A (Homo sapiens) 6480464 beta-Naphthoflavone results in increased expression of WNT5A mRNA CTD PMID:32858204 bisphenol A increases expression ISO Wnt5a (Mus musculus) 6480464 bisphenol A results in increased expression of WNT5A mRNA CTD PMID:24465770 and PMID:35598803 bisphenol A multiple interactions ISO WNT5A (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of WNT5A gene CTD PMID:31601247 bisphenol A decreases methylation ISO WNT5A (Homo sapiens) 6480464 bisphenol A results in decreased methylation of WNT5A gene CTD PMID:31601247 bisphenol A affects methylation ISO Wnt5a (Mus musculus) 6480464 bisphenol A affects the methylation of WNT5A promoter CTD PMID:27334623 bisphenol A decreases expression ISO WNT5A (Homo sapiens) 6480464 bisphenol A results in decreased expression of WNT5A mRNA CTD PMID:16029874 and PMID:27685785 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of WNT5A mRNA CTD PMID:25181051 and PMID:34947998 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of WNT5A mRNA CTD PMID:26496021 bisphenol F increases expression ISO Wnt5a (Mus musculus) 6480464 bisphenol F results in increased expression of WNT5A mRNA CTD PMID:30951980 bucladesine multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of WNT5A mRNA CTD PMID:20823114 cadmium atom multiple interactions ISO WNT5A (Homo sapiens) 6480464 Cadmium inhibits the reaction [Fulvestrant results in increased expression of WNT5A mRNA] CTD PMID:31646340 cadmium atom multiple interactions ISO Wnt5a (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT5A mRNA CTD PMID:36114956 cadmium atom decreases expression ISO WNT5A (Homo sapiens) 6480464 Cadmium results in decreased expression of WNT5A mRNA CTD PMID:31646340 cadmium dichloride multiple interactions ISO Wnt5a (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT5A mRNA CTD PMID:36114956 calciol increases expression ISO Wnt5a (Mus musculus) 6480464 Cholecalciferol results in increased expression of WNT5A mRNA CTD PMID:17170073 calcitriol increases expression ISO WNT5A (Homo sapiens) 6480464 Calcitriol results in increased expression of WNT5A mRNA CTD PMID:16002434 calcium atom increases expression ISO WNT5A (Homo sapiens) 6480464 Calcium results in increased expression of WNT5A mRNA CTD PMID:24658506 calcium atom multiple interactions ISO WNT5A (Homo sapiens) 6480464 CASR mutant form inhibits the reaction [Calcium results in increased expression of WNT5A protein] more ... CTD PMID:24658506 calcium atom increases secretion ISO WNT5A (Homo sapiens) 6480464 Calcium results in increased secretion of WNT5A protein CTD PMID:24658506 calcium(0) increases expression ISO WNT5A (Homo sapiens) 6480464 Calcium results in increased expression of WNT5A mRNA CTD PMID:24658506 calcium(0) increases secretion ISO WNT5A (Homo sapiens) 6480464 Calcium results in increased secretion of WNT5A protein CTD PMID:24658506 calcium(0) multiple interactions ISO WNT5A (Homo sapiens) 6480464 CASR mutant form inhibits the reaction [Calcium results in increased expression of WNT5A protein] more ... CTD PMID:24658506 cannabidiol multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of WNT5A mRNA CTD PMID:30096889 carbon nanotube increases expression ISO Wnt5a (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of WNT5A mRNA CTD PMID:25554681 carmustine affects response to substance ISO WNT5A (Homo sapiens) 6480464 WNT5A mRNA affects the susceptibility to Carmustine CTD PMID:16365179 casticin decreases expression ISO WNT5A (Homo sapiens) 6480464 casticin results in decreased expression of WNT5A mRNA CTD PMID:27862857 CHIR 99021 increases expression ISO WNT5A (Homo sapiens) 6480464 Chir 99021 results in increased expression of WNT5A mRNA CTD PMID:31711903 CHIR 99021 multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 more ... CTD PMID:31711903 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of WNT5A mRNA CTD PMID:18502319 chromium(6+) affects expression ISO WNT5A (Homo sapiens) 6480464 chromium hexavalent ion affects the expression of WNT5A mRNA CTD PMID:30690063 cisplatin multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of WNT5A mRNA and [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of WNT5A mRNA CTD PMID:27392435 and PMID:30871063 clofibrate increases expression ISO Wnt5a (Mus musculus) 6480464 Clofibrate results in increased expression of WNT5A mRNA CTD PMID:23811191 cocaine multiple interactions ISO Wnt5a (Mus musculus) 6480464 HDAC5 affects the reaction [Cocaine affects the expression of WNT5A mRNA] CTD PMID:17988634 copper atom multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of WNT5A mRNA CTD PMID:30911355 and PMID:31162603 copper atom decreases expression EXP 6480464 Copper results in decreased expression of WNT5A mRNA CTD PMID:30556269 copper(0) multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of WNT5A mRNA CTD PMID:30911355 and PMID:31162603 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of WNT5A mRNA CTD PMID:30556269 cyclosporin A decreases expression ISO WNT5A (Homo sapiens) 6480464 Cyclosporine results in decreased expression of WNT5A mRNA CTD PMID:20106945 and PMID:22147139 cyclosporin A increases expression ISO WNT5A (Homo sapiens) 6480464 Cyclosporine results in increased expression of WNT5A mRNA CTD PMID:27989131 cyfluthrin increases expression ISO WNT5A (Homo sapiens) 6480464 cyfluthrin results in increased expression of WNT5A mRNA CTD PMID:32028016 cypermethrin increases expression ISO WNT5A (Homo sapiens) 6480464 cypermethrin results in increased expression of WNT5A mRNA CTD PMID:32028016 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of WNT5A mRNA CTD PMID:18004065 D-glucose increases expression ISO WNT5A (Homo sapiens) 6480464 Glucose results in increased expression of WNT5A mRNA CTD PMID:29163160 D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA] CTD PMID:18004065 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of WNT5A mRNA CTD PMID:23914054 deguelin decreases expression ISO WNT5A (Homo sapiens) 6480464 deguelin results in decreased expression of WNT5A mRNA CTD PMID:33512557 diazinon affects expression EXP 6480464 Diazinon affects the expression of WNT5A mRNA CTD PMID:18502319 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of WNT5A mRNA CTD PMID:19130878 dibutyl phthalate decreases expression ISO Wnt5a (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of WNT5A mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of WNT5A mRNA CTD PMID:25213187 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of WNT5A mRNA CTD PMID:19130878 diethylstilbestrol multiple interactions ISO Wnt5a (Mus musculus) 6480464 WNT5A protein affects the reaction [Diethylstilbestrol results in decreased expression of HOXA10 mRNA] more ... CTD PMID:15073149 diethylstilbestrol increases expression ISO Wnt5a (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of WNT5A mRNA CTD PMID:15070830 and PMID:15073149 diuron increases expression EXP 6480464 Diuron results in increased expression of WNT5A mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO Wnt5a (Mus musculus) 6480464 Doxorubicin results in decreased expression of WNT5A mRNA CTD PMID:25896364 doxorubicin decreases expression ISO WNT5A (Homo sapiens) 6480464 Doxorubicin results in decreased expression of WNT5A mRNA CTD PMID:29803840 erastin multiple interactions ISO Wnt5a (Mus musculus) 6480464 erastin promotes the reaction [Silicon Dioxide results in increased expression of WNT5A protein] CTD PMID:37075931 erastin increases expression ISO Wnt5a (Mus musculus) 6480464 erastin results in increased expression of WNT5A protein CTD PMID:37075931 ferrostatin-1 multiple interactions ISO Wnt5a (Mus musculus) 6480464 ferrostatin-1 inhibits the reaction [Silicon Dioxide results in increased expression of WNT5A protein] CTD PMID:37075931 fluoranthene multiple interactions ISO Wnt5a (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of WNT5A mRNA CTD PMID:28329830 flusilazole affects expression ISO Wnt5a (Mus musculus) 6480464 flusilazole affects the expression of WNT5A mRNA CTD PMID:22634333 flusilazole decreases expression EXP 6480464 flusilazole results in decreased expression of WNT5A mRNA CTD PMID:28263823 folic acid affects expression ISO WNT5A (Homo sapiens) 6480464 Folic Acid affects the expression of WNT5A mRNA CTD PMID:17320366 fulvestrant multiple interactions ISO WNT5A (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of WNT5A gene more ... CTD PMID:31601247 and PMID:31646340 fulvestrant increases expression ISO WNT5A (Homo sapiens) 6480464 Fulvestrant results in increased expression of WNT5A mRNA CTD PMID:31646340 gemcitabine decreases expression ISO WNT5A (Homo sapiens) 6480464 Gemcitabine results in decreased expression of WNT5A mRNA CTD PMID:17039268 genistein decreases expression EXP 6480464 Genistein results in decreased expression of WNT5A mRNA CTD PMID:17341692 genistein increases expression ISO Wnt5a (Mus musculus) 6480464 Genistein results in increased expression of WNT5A mRNA CTD PMID:21810550 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of WNT5A mRNA CTD PMID:33387578 glucose decreases expression EXP 6480464 Glucose results in decreased expression of WNT5A mRNA CTD PMID:18004065 glucose increases expression ISO WNT5A (Homo sapiens) 6480464 Glucose results in increased expression of WNT5A mRNA CTD PMID:29163160 glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA] CTD PMID:18004065 glyphosate increases expression ISO WNT5A (Homo sapiens) 6480464 Glyphosate results in increased expression of WNT5A mRNA CTD PMID:31874349 glyphosate decreases response to substance EXP 6480464 WNT5A protein results in decreased susceptibility to Glyphosate CTD PMID:26688330 glyphosate decreases expression EXP 6480464 Glyphosate results in decreased expression of WNT5A mRNA and Glyphosate results in decreased expression of WNT5A protein CTD PMID:26688330 glyphosate affects expression EXP 6480464 Glyphosate affects the expression of WNT5A protein CTD PMID:28780397 homocysteine decreases expression ISO WNT5A (Homo sapiens) 6480464 Homocysteine results in decreased expression of WNT5A mRNA CTD PMID:17320366 hydrogen peroxide affects expression ISO WNT5A (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of WNT5A mRNA CTD PMID:20044591 hydroquinone increases expression ISO WNT5A (Homo sapiens) 6480464 hydroquinone results in increased expression of WNT5A mRNA CTD PMID:22960397 iron dichloride decreases expression ISO WNT5A (Homo sapiens) 6480464 ferrous chloride results in decreased expression of WNT5A mRNA CTD PMID:35984750 isotretinoin decreases expression ISO WNT5A (Homo sapiens) 6480464 Isotretinoin results in decreased expression of WNT5A mRNA CTD PMID:31711903 KN-93 multiple interactions ISO Wnt5a (Mus musculus) 6480464 KN 93 inhibits the reaction [Silicon Dioxide results in increased expression of WNT5A protein] CTD PMID:37075931 lipoic acid multiple interactions ISO Wnt5a (Mus musculus) 6480464 Thioctic Acid inhibits the reaction [Sodium Fluoride results in increased expression of WNT5A protein] CTD PMID:37739047 lipopolysaccharide multiple interactions ISO WNT5A (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:32048402 and PMID:35811015 lipopolysaccharide increases expression ISO WNT5A (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of WNT5A mRNA and Lipopolysaccharides results in increased expression of WNT5A protein CTD PMID:32048402 and PMID:35811015 loliolide increases expression ISO WNT5A (Homo sapiens) 6480464 loliolide results in increased expression of WNT5A mRNA CTD PMID:31601058 loliolide multiple interactions ISO WNT5A (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [loliolide results in increased expression of WNT5A mRNA] CTD PMID:31601058 LY294002 multiple interactions ISO WNT5A (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [loliolide results in increased expression of WNT5A mRNA] CTD PMID:31601058 maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of WNT5A mRNA and [Paraquat co-treated with Maneb] results in increased expression of WNT5A protein CTD PMID:29152652 medroxyprogesterone acetate multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of WNT5A mRNA more ... CTD PMID:20685861 and PMID:20823114 medroxyprogesterone acetate increases expression ISO WNT5A (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in increased expression of WNT5A mRNA CTD PMID:20685861 mercury dibromide increases expression ISO WNT5A (Homo sapiens) 6480464 mercuric bromide results in increased expression of WNT5A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA CTD PMID:27188386 methimazole increases expression EXP 6480464 Methimazole results in increased expression of WNT5A mRNA CTD PMID:30047161 methotrexate increases expression ISO WNT5A (Homo sapiens) 6480464 Methotrexate results in increased expression of WNT5A mRNA CTD PMID:17320366 methylmercury chloride decreases expression ISO WNT5A (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of WNT5A mRNA CTD PMID:28001369 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of WNT5A mRNA CTD PMID:34740672 mifepristone increases expression ISO WNT5A (Homo sapiens) 6480464 Mifepristone results in increased expression of WNT5A mRNA CTD PMID:17584828 mitomycin C affects response to substance ISO WNT5A (Homo sapiens) 6480464 WNT5A protein affects the susceptibility to Mitomycin CTD PMID:16217747 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of WNT5A mRNA CTD PMID:17341692 N-methyl-N-nitrosourea increases expression EXP 150530464 N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon RGD nickel atom increases expression EXP 6480464 Nickel results in increased expression of WNT5A mRNA CTD PMID:19130878 nickel sulfate increases expression ISO WNT5A (Homo sapiens) 6480464 nickel sulfate results in increased expression of WNT5A mRNA CTD PMID:22714537 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of WNT5A mRNA and nitrofen results in increased expression of WNT5A protein CTD PMID:20006014 Nor-9-carboxy-delta9-THC multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of WNT5A gene CTD PMID:30521419 ozone multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of WNT5A mRNA more ... CTD PMID:32699268 panobinostat multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WNT5A mRNA CTD PMID:27188386 panobinostat decreases expression ISO WNT5A (Homo sapiens) 6480464 panobinostat results in decreased expression of WNT5A mRNA CTD PMID:26272509 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of WNT5A mRNA CTD PMID:33387578 paracetamol decreases expression ISO Wnt5a (Mus musculus) 6480464 Acetaminophen results in decreased expression of WNT5A mRNA CTD PMID:37179516 paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of WNT5A mRNA and [Paraquat co-treated with Maneb] results in increased expression of WNT5A protein CTD PMID:29152652 perfluorohexanesulfonic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in decreased expression of WNT5A mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid increases expression ISO WNT5A (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of WNT5A mRNA CTD PMID:25812627 perfluorooctanoic acid increases expression ISO WNT5A (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of WNT5A mRNA CTD PMID:25812627 phenobarbital multiple interactions ISO Wnt5a (Mus musculus) 6480464 NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of WNT5A mRNA] CTD PMID:19482888 phenobarbital affects expression ISO WNT5A (Homo sapiens) 6480464 Phenobarbital affects the expression of WNT5A mRNA CTD PMID:19159669 phenobarbital increases expression ISO Wnt5a (Mus musculus) 6480464 Phenobarbital results in increased expression of WNT5A mRNA CTD PMID:19482888 phenylmercury acetate increases expression ISO WNT5A (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of WNT5A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA CTD PMID:27188386 phenytoin increases expression ISO WNT5A (Homo sapiens) 6480464 Phenytoin results in increased expression of WNT5A mRNA CTD PMID:31711903 picoxystrobin decreases expression ISO WNT5A (Homo sapiens) 6480464 picoxystrobin results in decreased expression of WNT5A mRNA CTD PMID:33512557 pirinixic acid increases expression ISO Wnt5a (Mus musculus) 6480464 pirinixic acid results in increased expression of WNT5A mRNA CTD PMID:18301758 pirinixic acid multiple interactions ISO WNT5A (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of WNT5A mRNA CTD PMID:19710929 potassium chromate decreases expression ISO WNT5A (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of WNT5A mRNA CTD PMID:22079256 potassium chromate increases expression ISO WNT5A (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of WNT5A mRNA CTD PMID:22714537 potassium chromate multiple interactions ISO WNT5A (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of WNT5A mRNA CTD PMID:22079256 progesterone multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of WNT5A mRNA CTD PMID:20660070 quercetin multiple interactions EXP 150530464 Quercetin inhibits the reaction [N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon] RGD rac-lactic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 Lactic Acid results in decreased expression of WNT5A mRNA CTD PMID:30851411 raloxifene multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of WNT5A mRNA CTD PMID:19059307 resveratrol decreases expression ISO WNT5A (Homo sapiens) 6480464 resveratrol results in decreased expression of WNT5A mRNA and resveratrol results in decreased expression of WNT5A protein CTD PMID:25061499 resveratrol multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of WNT5A mRNA CTD PMID:23557933 rotenone decreases expression ISO WNT5A (Homo sapiens) 6480464 Rotenone results in decreased expression of WNT5A mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO WNT5A (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:31711903 SB 431542 decreases expression ISO WNT5A (Homo sapiens) 6480464 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased expression of WNT5A protein CTD PMID:19901340 silicon dioxide decreases expression ISO WNT5A (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of WNT5A mRNA more ... CTD PMID:23806026 more ... silicon dioxide increases expression ISO Wnt5a (Mus musculus) 6480464 Silicon Dioxide results in increased expression of WNT5A protein CTD PMID:37075931 silicon dioxide multiple interactions ISO Wnt5a (Mus musculus) 6480464 erastin promotes the reaction [Silicon Dioxide results in increased expression of WNT5A protein] more ... CTD PMID:37075931 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of WNT5A mRNA CTD PMID:32721576 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA] CTD PMID:18004065 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of WNT5A mRNA and Simvastatin results in increased expression of WNT5A protein CTD PMID:18004065 and PMID:19968183 sodium arsenate increases expression ISO Wnt5a (Mus musculus) 6480464 sodium arsenate results in increased expression of WNT5A mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO WNT5A (Homo sapiens) 6480464 sodium arsenite results in decreased expression of WNT5A mRNA CTD PMID:12679051 sodium arsenite decreases expression ISO Wnt5a (Mus musculus) 6480464 sodium arsenite results in decreased expression of WNT5A mRNA CTD PMID:36209798 sodium arsenite increases expression ISO WNT5A (Homo sapiens) 6480464 sodium arsenite results in increased expression of WNT5A mRNA CTD PMID:20886546 and PMID:34032870 sodium fluoride increases expression ISO Wnt5a (Mus musculus) 6480464 Sodium Fluoride results in increased expression of WNT5A mRNA and Sodium Fluoride results in increased expression of WNT5A protein CTD PMID:37739047 sodium fluoride multiple interactions ISO Wnt5a (Mus musculus) 6480464 Thioctic Acid inhibits the reaction [Sodium Fluoride results in increased expression of WNT5A protein] CTD PMID:37739047 Soman decreases expression EXP 6480464 Soman results in decreased expression of WNT5A mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of WNT5A mRNA CTD PMID:30047161 sunitinib decreases expression ISO WNT5A (Homo sapiens) 6480464 Sunitinib results in decreased expression of WNT5A mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of WNT5A mRNA CTD PMID:19059307 temozolomide affects response to substance ISO WNT5A (Homo sapiens) 6480464 WNT5A mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide decreases expression ISO WNT5A (Homo sapiens) 6480464 Temozolomide results in decreased expression of WNT5A mRNA CTD PMID:31758290 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of WNT5A mRNA CTD PMID:16780995 tributylstannane decreases expression ISO WNT5A (Homo sapiens) 6480464 tributyltin results in decreased expression of WNT5A mRNA CTD PMID:28011154 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of WNT5A mRNA CTD PMID:33387578 trichostatin A decreases expression ISO WNT5A (Homo sapiens) 6480464 trichostatin A results in decreased expression of WNT5A mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA CTD PMID:27188386 trichostatin A increases expression ISO WNT5A (Homo sapiens) 6480464 trichostatin A results in increased expression of WNT5A mRNA CTD PMID:24935251 and PMID:26272509 troglitazone increases expression ISO WNT5A (Homo sapiens) 6480464 troglitazone results in increased expression of WNT5A mRNA CTD PMID:19140230 tunicamycin increases expression ISO Wnt5a (Mus musculus) 6480464 Tunicamycin results in increased expression of WNT5A mRNA CTD PMID:17127020 tunicamycin decreases expression ISO WNT5A (Homo sapiens) 6480464 Tunicamycin results in decreased expression of WNT5A mRNA CTD PMID:29453283 valproic acid affects expression ISO Wnt5a (Mus musculus) 6480464 Valproic Acid affects the expression of WNT5A mRNA CTD PMID:17292431 valproic acid increases expression ISO WNT5A (Homo sapiens) 6480464 Valproic Acid results in increased expression of WNT5A mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA CTD PMID:27188386 zoledronic acid increases expression ISO WNT5A (Homo sapiens) 6480464 zoledronic acid results in increased expression of WNT5A mRNA CTD PMID:24714768